Hot Pursuit     04-Jul-24
Sun Pharmaceuticals Industries Ltd rises for third consecutive session
Sun Pharmaceuticals Industries Ltd is quoting at Rs 1558.7, up 1.61% on the day as on 12:49 IST on the NSE. The stock is up 49.2% in last one year as compared to a 25.55% spurt in NIFTY and a 46.49% spurt in the Nifty Pharma index.

Sun Pharmaceuticals Industries Ltd gained for a third straight session today. The stock is quoting at Rs 1558.7, up 1.61% on the day as on 12:49 IST on the NSE. The benchmark NIFTY is up around 0.28% on the day, quoting at 24354.6. The Sensex is at 80227.97, up 0.3%. Sun Pharmaceuticals Industries Ltd has risen around 4.8% in last one month.

Meanwhile, Nifty Pharma index of which Sun Pharmaceuticals Industries Ltd is a constituent, has risen around 4.63% in last one month and is currently quoting at 19915.3, up 1.3% on the day. The volume in the stock stood at 11.37 lakh shares today, compared to the daily average of 22.61 lakh shares in last one month.

The benchmark July futures contract for the stock is quoting at Rs 1557.85, up 1.61% on the day. Sun Pharmaceuticals Industries Ltd is up 49.2% in last one year as compared to a 25.55% spurt in NIFTY and a 46.49% spurt in the Nifty Pharma index.

The PE of the stock is 120.96 based on TTM earnings ending March 24.

Previous News
  Market extends record rally for 2nd day; VIX slides 2.65%
 ( Market Commentary - Quick Review 04-Jul-24   15:58 )
  European Medicines Agency validates submission of MAA for Nidlegyâ„¢
 ( Corporate News - 04-Jul-24   15:04 )
  Sun Pharma gains on EMA nod for Nidlegy
 ( Hot Pursuit - 04-Jul-24   14:18 )
  Sun Pharmaceuticals Industries Ltd rises for third consecutive session
 ( Hot Pursuit - 04-Jul-24   13:05 )
  Sun Pharmaceuticals Industries Ltd Slides 0.84%
 ( Hot Pursuit - 03-Jul-24   09:30 )
  Sun Pharma completes acquisition of Taro
 ( Corporate News - 24-Jun-24   18:05 )
  Nifty below 23,500; European market declines
 ( Market Commentary - Mid-Session 21-Jun-24   13:34 )
  Broader mkt rallies; IT shares in demand
 ( Market Commentary - Mid-Session 21-Jun-24   10:32 )
  Sun Pharma enters into patent licensing agreement with Takeda
 ( Corporate News - 21-Jun-24   09:30 )
  Sun Pharma inks agreement with Takeda Pharma for commercialising Vonoprazan tablets in India
 ( Hot Pursuit - 21-Jun-24   09:26 )
  Sun Pharmaceuticals Industries to convene AGM
 ( Corporate News - 20-Jun-24   17:14 )
Other Stories
  Shalby drops after PAT slides 20% YoY to Rs 16 cr in Q1 FY25
  08-Jul-24   16:01
  PC Jeweller soars after PNB approves settlement
  08-Jul-24   15:26
  Godrej Inds gains after chemicals arm inks BTA to acquire Ethoxylation Unit II
  08-Jul-24   15:22
  GE Power sizzles after NTPC order win
  08-Jul-24   15:02
  Patel Engineering Ltd leads losers in 'A' group
  08-Jul-24   15:01
  Sundaram Multi Pap Ltd leads losers in 'B' group
  08-Jul-24   14:46
  Marine Electricals jumps after order win
  08-Jul-24   14:33
  Volumes soar at Metro Brands Ltd counter
  08-Jul-24   14:30
  Bank of India Q1 domestic deposits grow 10% YoY
  08-Jul-24   14:25
  Tata Motors Q1 global wholesales rises 2% YoY
  08-Jul-24   14:03
Back Top